Prof. Dr. Zha Yunhong
E-mail: yzha7808@ctgu.edu.cn
Faculty: First People's Hospital in Yichang City (People's Hospital of China Three
Gorges University)
Job Title: Professor, Chief Physician, Deputy Dean
1. Education
(1) September 2002-June 2007: M.D. & Ph.D, Huazhong University of Science & Technology
(2) September 1996-June 2001: B.S., Huazhong University of Science & Technology
2. Professional Experiences
(1) November 2018-now: First People's Hospital in Yichang City (People's Hospital of China Three Gorges University)
(2) October 2017-October 2018: Harvard Medical School
(3) March 2012-September 2017: First People's Hospital in Yichang City (People's Hospital of China Three Gorges University)
(4) October 2009-Febrary 2012: Medical College of Georgia
(5) March 2009-September 2009: First People's Hospital in Yichang City (People's Hospital of China Three Gorges University)
(6) September 2007-Febrary 2009: The Second Affiliated Hospital of Guangzhou Medical College
3. Research Directions
(1) Pathogenesis of Neurodegenerative Diseases and Drug Reorientation
(2) Pathogenesis of Neuroblastoma
4. Published Papers (since 2011)
(1) Liang Yu, Dandan Zhou, Lin Gao, Yunhong Zha*. Prediction of drug response in multilayer networks based on fusion of multiomics data, Methods. 2020, S1046-2023(20): 30104-3.
(2) Xinqian Hu, Ze’an Weng, Yingfeng Xia, Yunhong Zha*. Gene expression profiles and protein-protein interaction networks in neuroblastoma with MEIS2 depletion, J BUON. 2020, 25(5):2482-2489.
(3) Yingfeng Xia, Bingwei Ye, Jane Ding, Yajie Yu, Ahmet Alptekin, Muthusamy Thangaraju, Puttur D. Prasad, ZhiChun Ding, Eun Jeong Park, Jeong-Hyeon Choi, Bei Gao, Oliver Fiehn, Chunhong Yan, Zheng Dong, Yunhong Zha*, and Han-Fei Ding*. Metabolic reprogramming by MYCN confers dependence on the serine-glycine-one-carbon biosynthetic pathway, Cancer Res, 2019.
(4) Liang Yu, Shunyu Yao, Lin Gao and Yunhong Zha*. Conserved Disease Modules Extracted from Multilayer Heterogeneous Disease and Gene Networks for Understanding Disease Mechanisms and Predicting Disease Treatments, Frontiers in Genetics. 2019, 9(1).
(5) Liqun Yang, Yunhong Zha, JaneDing, Bingwei Ye, Mengling Liu, Chunhong Yan, Zheng Dong, Hongjuan Cui and Han-Fei Ding. Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation, Oncogenesis. 2019, 8(3).
(6) Yajie Yu, Ming Fang, Mengling Liu, Yingfeng Xia, Bingwei Ye, Junming Li, Yunhong Zha*, Xiangjun Cui*. Association between netrin G1 genetic variation and schizophrenia: a meta-analysis, Int J Clin Exp Med. 2017, 10(4):5985-5994.
(7) Mengling Liu, Yingfeng Xia, Jane Ding,Hongjuan Cui, Yunhong Zha*, Han-Fei Ding*. Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells, Cell Reports. 2016, 17:1-15.
(8) Y Zha, Y Xia, J Ding, J-H Choi, L Yang, Z Dong, C Yan, S Huang and H-F Ding. MEIS2 is essential for neuroblastoma cell survival and proliferation by transcriptional control of M-phase progression, Cell Death and Disease. 2014, 5, e1417; doi: 10. 1038/ cddis. 2014.370.
(9) Zha Y, Ding E, Yang L, Mao L, Wang X, McCarthy BA, Huang S, Ding HF. Functional dissection of HOXD cluster genes in regulation of neuroblastoma cell proliferation and differentiation, PloS One. 2012, 7(8): e40728.
5. Published Books (since 2011)
Yun Zhao, Junming Li, Bao’an Gao, Yunhong Zha, Jinghua Zhou, et al. Internship Handbook of Internal Medicine[M]. 2015
6. Research Projects (since 2011)
Presided over numbers of national, provincial, municipal and horizontal approved scientific research projects, contain 1 local guided by the central government science and technology project, 2 National Natural Science Foundation of China projects, 3 Open projects of Institute of basic medicine and State Key Laboratory of medical molecular biology (Chinese Academy of Medical Sciences), 7 provincial projects.
7. Honors and Awards (since 2011)
(1) 2020, One Hundred Outstanding Female Scientific and Technological Innovative Talents in Hubei Province.
(2) 2019, Hubei Famous Doctor Studio.
(3) 2018, Hubei Province New Century High Level Talent.
(4) 2018, Personnel Enjoying Special Allowance of Provincial Government.
(5) 2017, the 6th Youth Science and Technology Award of Yichang City.
(6) 2016, the 8th Yichang Excellent Expert.
(7) 2016, Teaching Achievement Award of China Three Gorges University.
(8) 2015, the 3rd prize of Science and Technology Progress of Hubei Province.
(9) 2015, Advanced Workers of Science and Technology Management of China Three Gorges University.
(10) 2014, Excellent Teachers of China Three Gorges University.
8. Membership of Professional Bodies
(1) Medical Consultant, China Tuberous Sclerosis Complex Rare Disease Care Center.
(2) Executive Director, Hubei Society of Pathophysiology.
(3) Deputy Secretary General, Hubei Stroke Society.
(4) Vice President, Hubei Association of Parkinson's Disease and Dyskinesia (the first session).
(5) Member, Hubei Provincial Committee of Integrated Traditional Chinese and Western Medicine.
(6) Director, Yichang Neurology Medical Quality Control Center.
(7) Chairman, Neurology Branch of Yichang Chinese Medical Association.
(8) Executive Director, Yichang Mental Health Association.
(9) Member, Psychiatric Branch of Yichang Medical Association.
Dr. LI LI
E-mail: 535495955@qq.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Associate Professor, Chief Physician
1. Education
(1) September 2015-now: Doctor's degree, Cardiovascular, the First Affiliated
College of Zhengzhou University
(2) September 2006-July 2009: Master's degree, Internal Medicine, Wuhan University
(3) September 1995-July 2000: Bachelor's degree, Clinical Medicine, Hubei Medical University
2. Professional Experiences
(1) May 2016-now: Ward of Emergency Internal Medicine, First Clinical Medical College of China Three Gorges University
(2) October 2014-May 2016: the Second Ward of Internal Medicine (Jiang Nan), First Clinical Medical College of China Three Gorges University
(3) July 2000-September 2014: Ward of Cardiovascular, First Clinical Medical College of China Three Gorges University
3. Research Directions
Basic and Clinical Research of Cardiovascular Diseases
4. Published Papers (since 2011)
(1) Li Li, Chunguang Qiu, Yang Liu, et al. Insights into the genetic basis of HMGB1 in Atrial fibrillation in a Chinese Han population, Cardiovascular Diagnosis and Therapy.
(2) Mu Qin*, Li Li, Xu Liu. Neural substrate of posterior left atrium: A novel modulation for inducibility and remodeling of atrial fibrillation in canine, PLoS ONE. 2017, 5.
(3) Wang Jichun, Li Li. c-Cbl inhibition: A novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury, International Journal of Cardiology. 2015, 186: 50-51.
(4) Min Liu, Jin Sun, Wen Wang, Jia-Wang Ding, Shu-Guo Li, Shubash Adhikari, Li Li, Jun Yang. RNA interference and ischemic injury, Mol Biol Rep. 2012, 3(3): 593-597.
(5) Li Li, Luying Jin, Min Liu, etc. A case of rheumatic heart disease with aortic dissection, Chinese Journal of Emergency Medicine. 2011, 20(11): 1148.
(6) Li Li, Min Liu, Jiawang Ding, etc. Acute myocardial infarction complicated with coronary artery aneurysm: a case report, Chinese Journal of Emergency Medicine. 2011, 20(12): 1315.
(7) Li Li, Min Liu, Jun Yang, etc. Pre-excitation syndrome and heredity, Chinese Journal of Gerontology. 2011, 31(9): 1705-1706.
(8) Li Li, Min Liu, Jiawang Ding, etc. Effect of clopidogrel on acute ST segment elevation myocardial infarction in patients over 60 years old, Chinese Journal of Gerontology. 2011, 31(5): 754-756.
5. Published Books (since 2011)
(1) Zhou Gang, Li Shijun, Li Li, et al. Treatment of integrated traditional Chinese and Western medicine in internal medicine emergency, Jilin Science and Technology Press, 2013.
(2) Zhao Yun, Li Junming, Li Li, et al. Practice Manual of internal medicine, Hubei science and Technology Press, 2016.
6. Research Projects (since 2011)
(1) 2019, Effect and Mechanism of Semen Raphani Water Extract on Homologous Diseases of Essential Hypertension and Type 2 Diabetes Mellitus, Project of Yichang Science and Technology Bureau, a19-301-10.
(2) 2019, Research on the Application of Seminar Teaching Method Combined with "1 + 1 + 1 + 1" Teaching Mode in Clinical Practice Teaching of International Medical Students, Higher Education Research Project of China Three Gorges University, 49.
(3) 2018, Research on the Application of Combined Teaching Based on Sp-cbl Mode in Internal Medicine Teaching for International Students, Open Education and Teaching Research Project of China Three Gorges University, kj2018022.
(4) 2016, Research and Practice of Case-based Three-dimensional Teaching Method Based on PDCA Cycle in Clinical Practice Teaching of International Medical Students, Higher Education Research Project of China Three Gorges University, J2016047.
(5) 2015, Association between SNPrs142125 in HMGB1 Gene and Atrial Fibrillation, Project of Yichang Science and Technology Bureau, a15301-06.
(6) 2015, Effects and Mechanisms of Matrix Modification of Atrial Innervation Area Mediated by G Protein Regulatory Factor 5 on Atrial Fibrillation, NSFC Youth Fund Project, 81400246.
7. Honors and Awards (since 2011)
(1) 2020.6, the 3rd prize of the 10th Teaching Achievement Award of China Three Gorges University.
(2) 2019.11, Good Teacher in the Eyes of International Students of China Three Gorges University.
(3) 2019, Famous Teacher of First Clinical Medical College of China Three Gorges University.
(4) 2018.11, the 3rd Prize of the 9th Teaching Achievement Award of China Three Gorges University.
(5) 2018.7, the 3rd Prize of Teaching Research and Teaching Reform Thesis of China Three Gorges University.
(6) 2018.6, Excellent Instructor of the 9th National College Students' Clinical Skills Competition.
(7) 2017.6, Excellent Instructor of the 8th National College Students' Clinical Skills Competition.
(8) 2016.8, Famous Teacher of First Clinical Medical College of China Three Gorges University.
(9) 2016.6, Excellent Instructor of the 7th National College Students' Clinical Skills Competition.
(10) 2015.11, Good Teacher in the Eyes of Foreign Students of China Three Gorges University.
(11) 2015.9, Excellent Teacher of Good Teacher in the Eyes of International Students of China Three Gorges University.
8. Membership of Professional Bodies
(1) 2016.12, Standing Member, Professional Committee, Geriatric Diseases of Hubei Microcirculation Society.
(2) 2010.12-2013.12, Member, Cardiovascular Medicine Branch of Yichang Medical Association.
Dr. Zhu Ping
E-mail: 810322077@qq.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Associate Professor, Associate Chief Physician
1. Education
(1) September 2013-september 2014: Senior visiting scholar, Department of Nephrology,
First Hospital of Peking University
(2) September 2008-June 2011: Doctor’s degree, Tongji Medical College of Huazhong University of Science & Technology
(3) September 2006-April 2007: Senior visiting scholar, National University of Toyama (Japan)
(4) September 2001-June 2004: Master’s degree, Medical College of China Three Gorges University
(5) September 1996-June 2001: Bachelor’s degree, Medical College of China Three Gorges University
2. Professional Experiences
(1) September 2011-now: Associate chief physician and associate professor, Responsible physician (group leader), Department of Nephrology, First Clinical Medical College of China Three Gorges University.
(2) September 2004-June 2008: Lecturer, Medical College of China Three Gorges University.
3. Research Directions
(1) Acute Kidney Injury
(2) Immunological Kidney Disease
(3) Vascular Access for Hemodialysis
4. Published Papers (since 2011)
(1) Zhu P, Zhou FD, Zhao MH. The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single Chinese center, Medicine (Baltimore). 2014.12, 93(28): 226.
(2) Zhu P, Zhou FD, Wang SX, Zhao MH, Wang HY. Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: a 10-year renal biopsy study from a single Chinese nephrology centre, Nephrology (Carlton). 2015.8, 20(8): 560-6.
(3) Yang F, Zhu P, Duan L, Yang L, Wang J. IL‑33 and kidney disease (Review), Mol Med Rep. 2016.1, 13(1): 3-8.
(4) Zhu P, Xie L, Ding HS, Gong Q, Yang J, Yang L. High mobility group box 1 and kidney diseases, Int J Mol Med. 2013, 31(4): 763-768.
(5) Zhu P, Xie L, Yang Y, Wang J, Gong F, Fang M. IL-10 promoter polymorphism associated with decreased risk of aGvHD after stem cell transplantation: a meta-analysis, Int J Hematol. 2013, 98(1): 102-111.
(6) Zhu P, Duan L, Chen J, Xiong A, Xu Q, Zhang H, Zheng F, Tan Z, Gong F, Fang M. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice, Hum Gene Ther, Hum Gene Ther. 2011, 22(7): 853-864.
(7) Wang J, Zhu P, Cui Z, Qu Z, Zhang YM, Wang F, Wang X, Wang JW, Zhu SN, Liu G, Zhou FD, Zhao MH. Clinical Features and Outcomes in Patients with Membranous Nephropathy and Crescent Formation, Medicine (Baltimore). 2015.12, 94(50): 2294.
5. Research Projects (since 2011)
(1) 2015.1-2018.12, Research on the Role and Molecular Mechanism of Microrna-24 in Diabetic Vascular Remodeling, 720000 yuan, in research, the second participant, General Project of NSFC, 81470387.
(2) 2012, Experimental Study on the Mechanism of a New Type of Alerting Element in Renal Ischemia-reperfusion Injury, General Project of Hubei Provincial Natural Science Foundation, fkb03708.
(3) Research on the Mechanism of Alerting Element in Acute Kidney Injury, Yichang Scientific Development Project, a13301-02.
(4) To Study the New Molecular Mechanism of Resveratrol in Protecting Acute Kidney Injury from SIRT1 Blocking the Release of HMGB1, Yichang Scientific Development Project, a20-2-002.
(5) From SIRT1 Blocking the Release of HMGB1 in the Nucleus, to Study the Molecular Mechanism of Papain Protecting Acute Kidney Injury, Scientific Research Program of Hubei Provincial Department of Education, b2017024.
(6) Active Vitamin D3 up Regulates Autophagy Activity to Prevent Diabetic Nephropathy Podocyte Injury and its Mechanism Research, in research, participated in, National Natural Science Foundation Youth Project, 81600567.
6. Honors and Awards (since 2011)
(1) 2012-2020, Top Talent in Science and Technology of First Clinical Medical College of China Three Gorges University.
(2) 2015-2018, Excellent Clinical Doctor of First Clinical Medical College of China Three Gorges University.
7. Membership of Professional Bodies
(1) Membership, Kidney Disease Branch of Hubei Society of Biological Immunology.
(2) Membership, Blood Purification Branch of Hubei Microcirculation Society.
(3) Membership, Kidney Disease Branch of Yichang Medical Association.
(4) Membership, Nutrition Branch of Yichang Medical Association.
Dr. Gong Zheng
E-mail: gongzheng119898@163.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Associate Professor, Associate Chief Physician
1. Education
(1) September 2009-July 2012: M.D., Jinan University
(2) September 2005-July 2008: M.M., Guangxi University of Chinese Medicine
(3) September 1998-July 2003: B.A. in Chinese Medicine, Hubei University of Chinese Medicine
2. Professional Experiences
(1) July 2012-now: Associate Chief Physician, First Clinical Medical College of China Three Gorges University
(2) July 2018- October 2018: Respiratory interventional therapy training in Department of Bronchoscopy of Shanghai Pulmonary Hospital
(3) September 2016-March 2017: Pulmonary physician training in Department of Respiratory of Beijing Chaoyang Hospital, Capital University of Medical Science
(4) July 2008- September 2009: Attending Doctor, Ge Zhouba Central Hospital
(5) July 2003- September 2005: Physician, Quyuan Town Hospital in Zigui County
3. Research Directions
(1) Respirology
(2) Practice of Interventional Pulmonology
4. Published Papers (since 2011)
(1) Gong Z, An-rong Jiang, Xiao-gang Peng, Man Yuan. Typha angustifolia extract reduces diet-induced hyperlipidemia in rats, Chinese Herbal Medicines. 2019, 11(1): 98-102.
(2) Gong Z, Gong P, Zhang L, Y., Wang Y, Q., Jing Z, Dong C, S. Effect of 15 cases with continuous blood purification therapy on severe heat stroke, Journal of Internal Intensive Medicine. 2017, 10(5): 87-90.
(3) GONG Z, GONG Ping, JING Zhu, WANG Yong-quan, ZHANG Ling-yun, ZHAO Bi-jun, XIANG Guang-ming, CHEN Shi-xiong. Aiyu Capsule or Fufang Banmao Capsules combined with icotinib hydrochloride in the treatment of advanced non-small cell lung cancer. 2017, 39(11):8-14.
(4) Gong Z, Gong P, Jing Z, Zhang LY, Wang YQ, Xiang GM, et al. Relation of CT image and galactomannan for invasive pulmonary aspergillosis, J Chin Clin Med Imaging. 2017, 28(1): 27-9.
(5) Gong Z, Gong l, LV PY, Zhang JM, Zhang CY, Dong CJ, et al. The effect of Total Flavonoids from Bergamot on Blood Lipid and Atherosclerosis Related Risk factor in hyperlipidemia rabbit, Chinese Journal of Microcirculation. 2016, 26(1): 14-7.
(6) Gong Z, Zhang CY, Wang YH, Zhan M, Zhang lY, Wang YH, et al. Interventional bronchoscopy combined with local mitomycin C clinical study on the treatment of airway constriction after tracheotomy, China Journal of Endoscopy. 2016, 22(4): 6-9.
(7) Gong Z, Gong P, Zhang CY, Zhang LY, Abbott KA, Wang YQ, et al. Bronchial thermoplasty on cure of 52 patients with severe asthma, Chin J Clinicians. 2016, 10(19): 2958-61.
(8) Gong Z, Gong P, Zhang C, Y., Dong C, J. Use of Metal Stenting Combined with cisplatin in Therapy for airway stenosis by Pulmonary Carcinoma, Chin J Lung Dis. 2016, 9(4): 413-4.
(9) Gong Z, Zhan M, Zhang L, Y., Gong P, Wang Y, H., Cui C, et al. Dynamic changes of galactomannan for invasive pulmonary aspergillosis and relation with CT image, Chin J Mycol. 2016, 11(4): 205-8.
(10) Gong Z, Zhang CY, Wang YH, Gong P, Dong CJ, Cheng SX. Metal stent plus radioactive 125I seed implantation for the treatment of airway stenosis caused by pulmonary carcima: clinical comparison with metal stent plus radiotherapy, J Intervent Radial. 2016, 25(10): 876-80.
(11) Gong Z, Gong L, Tang HM, Guo lY, Xing YY, Wang XM, et al. Research progress of drug abuse and HIV-1 associated neurocognitive disorder, Chin J Exp. 2015, 9(1): 116-9.
(12) Gong Z, Yang L, Tang H, Pan R, Xie S, Guo L, et al. Protective effects of curcumin against human immunodeficiency virus 1 gp120 V3 loop-induced neuronal injury in rats, Neural Regen Res. 2012, 7(3): 171-5. PMCID: 4353109.
(13) Gong Z, Tang HM, Wang JB, Dong J, Yang LJ, Deng QY. Protective effect of curcumin against gpl20 V3 loop-induced neuronal synaptosomes insult in rat hippocampus, Journal of Jinan University. 2016, 33(2).
(14) Chen G, L., Gong Z, Liu S, S., Jiang M, L., Pan R, Xing Y, Y., et al. Role of morphine and gp120 V3 loop in learning and memory dysfunction in rats, Chinese Journal of Pathophysiology. 2016, 32(5): 825-30.
(15) Luo M, Wang MH, Gong Z. Evaluation on clinical curative effect of treating chronic obstructive pulmonary disease patients with syndrome of deficiency of lung qi during stable period with Xingmai Bufei Decoction, CJTCM P. 2016, 31(2): 682-4.
(16) Gong P, Wang P, Gong Z, Zhang CY. One Case: Pulmonary Artery Sarcoma with Pulmonaryartery trunk congestion, Journal of Cardiovascular & Pulmonary Diseases. 2016, 35(7): 559.
(17) Guo L, Xing Y, Pan R, Jiang M, Gong Z, Lin L, et al. Curcumin protects microglia and primary rat cortical neurons against HIV-1 gp120-mediated inflammation and apoptosis, PLoS One. 2013, 8(8): e70565. PMCID: 3735595.
(18) Wang J, B., Gong Z, Dong J, Pan R, Tang HM, Xiong GY. Protective effect and mechanism of curcumin on ActD／TNF--a-induced syner-gistically apoptosis in PC12 cell, Chin J Cell Mol Immunol. 2012, 28(5): 484-7.
5. Published Books (since 2011)
(1) Internship Handbook of Internal Medicine, Chapter 1 Section: Tuberculosis Editorial board member.
(2) Diagnosis and treatment strategies of Interventional, Chapter 10: Respiratory Whole-lung Lavage Editorial board member.
6. Research Projects (since 2011)
(1) Mechanism of Blocking GSK3-ULK1 Signaling Pathway about Borneol-curcumin in Autophgy Induced by Human Immunodeficiency Virus 1 gp120 V3 Loop in Rats, Hubei Province Health and Family Planning Scientific Research Project, WJ2015MB17.
(2) Effects and Signaling Pathway of Neurons Autophagy in Pulmonary Encephalopathy, Scientific Research Development Fund Projects, KFJ2013009.
(3) Mechanism of Blocking GSK3-ULK1 Signal Pathway about Curcumin in Autophgy Induced by Human Immunodeficiency Virus 1 gp120 V3 Loop, Science and Technology Fund of Yichang City, A14301-06
7. Honors and Awards (since 2011)
2013, Excellent Teacher of China Three Gorges University.
8. Membership of Professional Bodies
Director, World Association of Endoscopists, Respiratory Endoscopy Association.
Dr. Dai Chibing
E-mail: dchibing@126.com
Faculty: Second Clinical Medical College of China Three Gorges University
Job Title: Associate Professor, Chief Physician
1. Education
(1) September 2009-June 2012: M.D. & Ph.D., Tongji Medical College of Huazhong
University of Science & Technology
(2) September 2003-June 2006: M.M., Second Clinical Medical College of China Three Gorges University
2. Professional Experiences
(1) August 2006-now: Second Clinical Medical College of China Three Gorges University
(2) August 1997-August 2003: Third People's Hospital of Yichang City
3. Research Directions
(1) Gastrointestinal Motility
(2) Intestinal Inflammation and Intestinal Microecology
4. Published Papers (since 2011)
(1) Peng-Chun Yang, Xi-Jun Li, Yan-Hua Yang, Wei Qian, Shi-Yu Li, Cai-Hua Yan, Jing Wang, Qin Wang, Xiao-Hua Hou, Chi-Bing Dai*. The influence of bifidobacterium bifidum and bacteroides fragilis on enteric glail cell-derived neurotrophic factors and inflammasome, Inflammation. 2020, 43(6): 2166-2177.
(2) Chibing Dai, Na Liu, Wenmei Chen, Wei Qian, Xiaohua Hou*. Simo Decoction promotes antral circular strips contraction mainly via muscarinic M3 receptor, Journal of Ethnopharmacology. 2012, 144(2): 270-276.
(3) Chibing Dai, Wei Qian, Na Liu, Jing Gong, Wenmei Chen, Xiaohua Hou*. Simo Decoction stimulates contractions of antral longitudinal smooth muscle via multitudinous mechanisms, Journal of evidence-based complementary & alternative medicine. 2013, 18(2): 113-120.
5. Published Books (since 2011)
Internship Handbook of Internal Medicine, the Publishing House of Science and Technology of Hubei Province, ISBN: 978-7-5352-8470-9, 2016.
6. Research Projects (since 2011)
(1) 2018, Study on the Relationship between Visceral Hypersensitivity and Enteric Glial Cell Distribution and Enteric Glial Cell-derived Nutritional Factors, Project of Yichang Science and Technology Bureau.
(2) 2014, Study on Central Nerve Regulation Mechanism of Simo Decoction on Diabetic Gastroparesis, Natural Science Foundation of Hubei Province.
(3) 2014, The Role of Inflammasome NLRP6 in PI-IBS Immune Activation, Key Project of Natural Science Research of Hubei Provincial Department of Education.
(4) 2013, The Role of Enteric Glial Cells in the Pathogenesis of PI-IBS, China Three Gorges University Talent Fund Project.
7. Honors and Awards (since 2011)
(1) 2013-2019, Outstanding Teacher of China Three Gorges University.
(2) 2016, the 8th Outstanding Expert of Yichang City.
(3) 2016, the 3rd Prize of Science and Technology Progress Award of Yichang City.
(4) 2015, the 3rd Outstanding Talent of Wu Jiagang District in Yichang City.
(5) 2014, the 1st Prize of the 11th Natural Science Outstanding Academic Paper of Yichang City.
8. Membership of Professional Bodies
(1) Member, Digestive Branch of the Hubei Medical Association.
(2) Deputy Chairman, Digestive Disease Branch of the Yichang Medical Association of Hubei Province.
(3) Standing Committee Member, Digestive disease Minimally Invasive Diagnosis and Treatment of Hubei Province Microcirculation Society.
(4) Deputy Team Leader, Digestive Endoscopy Quality Control Expert Group of Yichang City, Hubei Province.
(5) Deputy Team Leader, Infectious Disease Quality Control Expert Group of Yichang City, Hubei Province.
Dr. Wang Tao
E-mail: taowang0210@whu.edu.cn
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Attending Doctor
1. Education
(1) September 2014-June 2017: Ph.D. in Neurology, Wuhan University
(2) September 2010-June 2013: M.D. in Neurosurgery, China Three Gorges University
(3) September 2005-June 2010: Bachelor of Clinical Medicine, China Three Gorges University
2. Professional Experiences
July 2017-now: First Clinical Medical College of China Three Gorges University
3. Research Directions
(1) Ischemic Stroke
(2) Cognitive Disorders
4. Published Papers (since 2011)
(1) Wang T(#), Sun D, Liu Y, Mei B, Li H, Zhang S, et al. The Impact of Carotid Artery Stenting on Cerebral Perfusion, Functional Connectivity, and Cognition in Severe Asymptomatic Carotid Stenosis Patients, Front Neurol. 2017, 8: 403.
(2) Wang T(#), Mei B, Zhang J. Atherosclerotic carotid stenosis and cognitive function, Clin Neurol Neurosurg. 2016, 146: 64-70.
(3) Wang T(#), Zhao HS, Zhang QL, Xu CL, Liu CB. Generation of transgene-free induced pluripotent stem cells with non-viral methods, Chin Med Sci J. 2013, 28(1): 50-4.
(4) Wang T(#), Xiao F(#), Wu G, Fang J, Sun Z, Feng H, et al. Impairments in Brain Perfusion, Metabolites, Functional Connectivity, and Cognition in Severe Asymptomatic Carotid Stenosis Patients: An Integrated MRI Study, Neural plasticity. 2017, 2017: 8738714.
(5) Gao L(#), Wang T(#), Qian T, Xiao F, Bai L, Zhang J, et al. Severe asymptomatic carotid stenosis is associated with robust reductions in homotopic functional connectivity, Neuroimage Clin. 2019, 24: 102101.
(6) Xiao F(#), Wang T(#), Gao L, Fang J, Sun Z, Xu H, et al. Frequency-Dependent Changes of the Resting BOLD Signals Predicts Cognitive Deficits in Asymptomatic Carotid Artery Stenosis, Front Neurosci. 2018, 12: 416.
(7) Liu Y, Fan YT, Liu YM, Wang T, Feng HL, Liu GZ, et al. A retrospective study of branch atheromatous disease: Analyses of risk factors and prognosis, J Huazhong Univ Sci Technolog Med Sci. 2017, 37(1): 93-9.
(8) Deng XY WH, Wang T, Fang XT, Zou LL, Li ZY, Liu CB. Non-viral methods for generating integration-free, induced pluripotent stem cells, Curr Stem Cell Res Ther. 2015, 10(2): 153-8.
(9) Zou LL, Ma JL, Wang T, Yang TB, Liu CB. Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System, Curr Neuropharmacol. 2013, 11(2): 197-208.
5. Research Projects (since 2011)
Enhancement of Anti-oxidative Capacity of Nrf-2 by Novel Cell-penetrating Peptides in Alleviating the Impairment of White Matter Brain Network and Cognition Induced by Chronic Hypoperfusion, 230,000 yuan, PI.
6. Honors and Awards (since 2011)
(1) 2020, the 1st Class Award of Yichang Excellent Academic Paper.
(2) 2018, the 2nd Class Award of China Stroke Prevention and Treatment Association Excellent Academic Paper.
(3) 2017, the 1st Award of Hubei Science and Technology Advance.
7. Membership of Professional Bodies
(1) Committee Member, Neurodegeneration group, China Microcirculation Association.
(2) Committee Member, Neurointerventional group, Hubei Cerebral Vascular Diseases Association.
(3) Committee Member, Yichang Neurology Association.
Dr. Tian Chunlei
E-mail: cltianyc@163.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Deputy Chief Physician
1. Education
(1) September 2007-June 2010: Ph.D. in Neurosurgery, Tongji Medical College of
Huazhong University of Science & Technology
(2) September 2004-June 2007: Master of Neurosurgery, Tongji Medical College of Huazhong University of Science & Technology
(3) September 1999-June 2004: Bachelor of Clinical Medicine, Jining Medical College
2. Professional Experiences
(1) July 2016-now: Deputy chief physician, First Clinical Medical College of China Three Gorges University
(2) June 2010-now: Lecturer, Institute of Neurology, China Three Gorges University
(3) August 2014-February 2015: Studied in Institute of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University
(4) January 2012-July 2012: Visiting scholar, Neurosurgery, HELIOS Hospital, Berlin, Germany
(5) June 2010-July 2016: Attending physician, First Clinical Medical College of China Three Gorges University
3. Research Directions
Neurosurgery
4. Published Papers (since 2011)
(1) Tian C, Wang X, Wu S, Liu Y, Luo R. Letter: Pain Outcomes Following Microvascular Decompression for Drug-Resistant Trigeminal Neuralgia: A Systematic Review and Meta-Analysis, Neurosurgery. 2020, 86(3): E353- E354.
(2) Shengmei Wu, Xiaodan Wang, Xuejun Zhang, Chunlei Tian. The application of vacuum negative pressure cupping combing with pressure bandage in the treatment of deep pressure ulcers. Asian Journal of Surgery, Asian J Surg. 2020, 43(8): 858-859.
(3) Chunlei Tian，Xiongwei Wang，Xiaodan Wang，Wenping Xiong. Letter: An Imaginary Hemostasis Device for Sinus Bleeding During Transsphenoidal Surgery, Neurosurgery. 2016, 78(1): E160-E161.
(4) Chunlei Tian, Xiongwei Wang, Xiaodan Wang, Lei Wang, Xuguang Wang, Shengmei Wu, Zhixian Wan. Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture, Experimental and Clinical Transplantation. 2013, 11(2): 176-181.
5. Research Projects (since 2011)
(1) mTOR Pathway was Activated by TRPV1: the Epileptogenesis Mechanism of Focal Cortical Dysplasia? National Natural Science Foundation of China Youth Project, 81701278.
(2) The Mechanism of Adenosine Inhibiting Epileptic Seizures, Natural Science Research Program of Hubei Education Department, Q20161211.
6. Honors and Awards (since 2011)
(1) 2016, the 3rd prize of Science and Technology Progress Award of Hubei Province.
(2) 2016, the 3rd prize of Science and Technology Progress Award of Yichang City.
7. Membership of Professional Bodies
(1) Standing Director, Hubei Anti-Epilepsy Association.
(2) Standing Committee Member, Neurology Association, Yichang Medical Association.
Dr. Wang Junjie
E-mail: 258888658@qq.com
Faculty: Second Clinical Medical College of China Three Gorges University
1. Education
(1) September 2010-June 2013: M.D. in Obstetrics and Gynecology, Tongji Medical College
of Huazhong University of Science & Technology
(2) September 2006-June 2009: M.M. in Obstetrics and Gynecology, China Three Gorges University
(3) September 1995-June 2000: M.B. in Clinical Medicine, Wuhan University
2. Professional Experiences
July 2000-now: Department of Gynecology, Second Clinical Medical College of China Three Gorges University
3. Research Directions
Gynecological Oncology
4. Published Papers (since 2011)
(1) Junjie Wang, Lili Yu, Jing Cai, Jinghui Jia, Yanping Gao, Minling Liang, Zehua Wang*. The Role of EZH2 and DNA Methylation in hMLH1 Silencing in Epithelial Ovarian Cancer, Biochemical and Biophysical Research Communications. 2013.4, 433(4): 470-476.
(2) Junjie Wang, Jing Cai, Yanping Gao, Lili Yu, Jinghui Jia, Qingchun Deng, Zehua Wang*. Effect of EZH2 downregulation on E-cadherin expression in ovarian cancer cell line, Journal of Huazhong University of Science and Technology (Medical). 2013.8, 42(4).
(3) Jinghui Jia, Yuan Zhang, Jing Cai, Junjie Wang, Hui Ding, Jun Zhou, Fang Fang, Zehua Wang*. A Novel Function of Protein Kinase B as A Inducer of the Mismatch Repair Gene hPMS2 Degradation, Cellular Signalling. 2013.6, 25(6): 1498-504.
(4) Jun Zhou, Jing Cai, Jinghui Jia, Ding Hui, Junjie Wang, Zehua Wang*. Proteomic identification of target proteins following Drosha knockdown in cervical cancer, Oncology Reports. 2013.8, 30(5): 2229-2237.
(5) Ping Wu, Junjie Wang*. PBL model design and application in gynecology and obstetrics teaching research, Chongqing Medical Journal, 2014.6
(6) Bei Wu, Zhiying Li, Junjie Wang*. Research Progress of DZNep in Tumor Therapy, Tumor. 2016, 36(8): 938-943.
(7) Wu Zhou, Junjie Wang*. The development of eIF5A2 gene in malignant tumor, Oncology. 2018, 38 (3): 270-277.
(8) Wu Zhou, Junjie Wang*. CD13 research progress in the malignant tumor, Life Science. 2018, 30(3): 267-275.
(9) Qi Liu, Lin Lin, Junjie Wang*. Progress in N6-methyladenosine epigenetic modification in tumors, Tumor. 2019, 39(03): 229-234.
(10) Lin Lin, Qi Liu, Wenqian Zhou, Junjie Wang*. JNK signaling pathway in fibrotic disease, Chemistry of Life. 2020, 40(5): 701-706.
(11) Wenqian Zhou, Lin Lin, Qihua Wang, Junjie Wang*. Advances in the research of the expression and mechanism of miRNA-663a in inflammation and cancer, Chemistry of Life. 2020, 40(11): 2000-2005.
5. Published Books (since 2011)
Internship Manual in Obstetrics and Gynecology, Science and Technology of China Press, 2016 (Associate Editor).
6. Research Projects (since 2011)
(1) 2019.2-2020.12, Expression of PDGF, Upa, E-cadherin and their correlation in endometrial tissue of patients with intrauterine adhesions, 30,000 yuan, in research, Host, Yichang Medical and Health Research Project, A18301-08.
(2) 2018.1-2019.12, DZNep-mediated miRNA targeted therapy for ovarian cancer and its mechanism, 50,000 yuan, in research, Host, Hubei Provincial Natural Science Foundation Project, 2017CFB557.
(3) 2018.1-2019.12, Expression of MMP-9, TIMP-1 and CDH13 in endometrial tissue of patients with intrauterine adhesions and their correlation, 30,000 yuan (Self-funded), in research, Host, Guiding Project of Scientific Research Plan of Hubei Provincial Department of Education, B2017026.
(4) 2018-2019, GC7-mediated EIF5A2 regulation of EMT's anti-ovarian cancer mechanism and targeted therapy, 10,000 yuan, in research, Host, Tumor Microenvironment and Immunotherapy Hubei Provincial Key Laboratory Open Fund (Three Gorges University), 2018KZL10.
(5) 2016-2018, Progress in Obstetrics and Gynecology, 20,000 yuan, Completed, Ranked second, Hubei Province Graduate Excellent Course Construction Project.
(6) 2015.1-2017.12, Study on the Mechanism of Chemically Mediated Active Free Radicals on DNA, 250,000 yuan, Completed, Ranked fourth, National Natural Science Foundation of China, 21407093.
(7) 2015-2016, Construction and exploration of evaluation system for postgraduates of obstetrics and gynecology, Completed, Host, China Three Gorges University 2015 Higher Education Research Project, 1562.
(8) 2014.1-2016.12, BNIP3 Mediated Platinum-induced DNA Damage Promoting Apoptosis and the Mechanism of Drug Resistance in Ovarian Cancer, 230,000 yuan, Completed, Ranked Second, National Natural Science Foundation of China, 81302265.
(9) 2014.1-2016.12, DZNep-mediated EZH2 regulation of CDH13 methylation and anti-ovarian cancer mechanism and targeted therapy, 280,000 yuan, Completed, Host, National Natural Science Foundation of China, 81302269.
(10) 2009-2010, Clinical and Experimental Research on the Receptivity of Endometrium to Embryos, 80,000 yuan, Completed, Ranked Third, Major research project of Hubei Provincial Department of Education, Z20091302.
7. Honors and Awards (since 2011)
(1) 2019, Top Young Medical Talents in Hubei Province, Health Commission of Hubei Province.
(2) 2015, the 1st Prize of Yichang Science and Technology Progress Award, the Project "Epigenetics Molecular Targeted Therapy and Clinical Application of Gynecological Tumors", the Government of Yichang.
(3) 2015, Outstanding Teacher of China Three Gorges University.
(4) 2015, the Most Beautiful Doctor in Yichang, Three Gorges Radio and Television.
(5) 2015, Top Ten Outstanding Youths of China Three Gorges University.
(6) 2014, the 2nd Prize of China Three Gorges University Science and Technology Progress Award, the Project "Experimental study on the regulation of hMLH1 gene expression by EZH2 and DNA methylation in ovarian cancer", China Three Gorges University.
(7) 2014, the 2nd Prize of Yichang Science and Technology Progress Award, the Project "Experimental study of miR-34a combined with soluble PD-1 protein for the treatment of cervical cancer", the Government of Yichang.
(8) 2014, Yichang Outstanding Youth Science and Technology Award, the Government of Yichang.
8. Membership of Professional Bodies
(1) 2019-2022, Committee Member, the 3rd Committee of Gynecological Oncology Branch of Hubei Medical Association.
(2) 2019-2022, Committee Member, the 1st Committee of Gynecological Endocrinology of Hubei Province.
(3) 2018-2023, Committee Member, Pelvic Floor Rehabilitation Committee of China Maternal and Child Health Association.
(4) 2018-2021, Standing Committee Member, Obstetrics and Gynecology Branch of Yichang Medical Association.
(5) 2015, Backbone of Gynecology PI Team of China Three Gorges University.
(6) 2014, Deputy Director, Institution of Gynecological Oncology, China Three Gorges University.
Dr. Luo Jun
E-mail: luojunne@163.com
Faculty: Second Clinical Medical College of China Three Gorges University
Job Title: Associate Professor, Chief Physician
1. Education
(1) September 2008-June 2011: Doctor's degree, Tongji Medical College of Huazhong
University of Science & Technology
(2) September 2000-June 2003: Master's degree, Tongji Medical College of Huazhong University of Science & Technology
(3) September 1992-June 1997: Bachelor's degree, Xiangya School of Medicine of Central South University
2. Professional Experiences
June 1997-now: Second Clinical Medical College of China Three Gorges University
3. Research Directions
(1) Pediatric Kidney Disease Direction
(2) Pediatric Immune Disease Direction
4. Published Papers (since 2011)
(1) TGF-β/Smads signaling pathway and renal fibrosis, International Journal of Urology, 2017-02.
(2) Research progress of urinary proteomics in IgA nephropathy, Hainan Medical Journal, 2017-06.
(3) Research progress on early non-invasive examination of IgA nephropathy, Medical Review, 2017-07.
(4) A case of congenital bladder fistula misdiagnosed as repeated upper respiratory tract infection, Hainan Medical Journal, 2015-07.
5. Published Books (since 2011)
Pediatric Practice Manual (Clinical Practice Guidance Series for International Students), ISBN 978-7-5352-8469-3, associate editor.
6. Research Projects (since 2011)
(1) Mechanism of Astragalus Membranaceus on IgA Nephropathy in Mice Based on TGF-β1/Smads Pathway.
(2) Mechanism of Astragalus Polysaccharide in Treating IgA Nephropathy Based on Up-regulating Cosmic Protein and Reversing Abnormal Glycosylation of IgA1 Molecule.
(3) Effect of Vascular Endothelial Growth Factor on Podocyte Reduction in IgA Nephropathy and its Mechanism.
7. Honors and Awards (since 2011)
(1) Charity Advanced Individual in Yichang City.
(2) Outstanding Individual with Double Posts in the United Front Work Department of China Three Gorges University.
8. Membership of Professional Bodies
(1) Member, Children's Kidney Disease Professional Committee of World Chinese Medical Doctor Association.
(2) Member, Infection Professional Committee of Children's Critical Care Physician Branch of Chinese Medical Doctor Association.
(3) Member, Immunology Group of Pediatrics Branch of Hubei Provincial Medical Association.
(4) Member, Hubei Provincial Expert Group on Children's Enuresis Management.
(5) Chairman, Pediatrics Branch of Yichang Medical Association.
Prof. Dr. Li Hong
E-mail: 1741433022@qq.com
Faculty: Second Clinical Medical College of China Three Gorges University
Job Title: Professor, Chief Physician
1. Education
(1) September 2002-May 2005: On-the-job postgraduate study in Huazhong University of
Science & Technology
(2) September 1999-July 2002: On-the-job undergraduate study in Clinical Medicine of China Three Gorges University
(3) September 1983-July 1986: Clinical Medical study in Yichang Medical College
2. Professional Experiences
(1) December 1998-Now: Radiology Department of Second Clinical Medical College of China Three Gorges University
(2) September 1997-August 1998: Radiology department of the Second People's Hospital of Yidu City
(3) July 1986-October 1998: Radiology department of Second Clinical Medical College of China Three Gorges University
3. Research Directions
(1) Interventional Radiology
(2) Image Diagnostics
4. Published Papers (since 2011)
(1) Li H, Hu Y, Li N, Zhou Y, et al. Liver Fibrosis and Five Year Survival of Hepatocellular Cancer Cases Undergoing Transcatheter Arterial Chemo Embolization Using Small Doses, Asian Pacific Journal of Cancer Prevention. 2012, 134(4).
(2) Li H, Hu Y, Li N, Zhou Y, et al. Value of hepatic diffusion‑weighted magnetic resonance imaging in evaluating liver fibrosis following transarterial chemoembolization with low doses of chemotherapy, Exp Ther Med. 2014.8, 82(2).
(3) He L, Li H. Application of DTI in diagnosis of lumbar disc degeneration and nerve root compression, Practical Radiology. 2017.2, (38): 471-473.
(4) Deng L, Li H. MRI in the prenatal identification of placenta implantation: systematic review and meta-analysis, Radiologic Practice. 2018.5, (33): 478-482.
(5) Jiang G, Li H. Research progress of bone age assessment with traditional methods, new methods and artificial intelligence methods, Chinese Journal of Interventional Imaging and Therapy. 2019.6, (16): 376-379.
(6) Zhang Y, Li H. Current situation of imaging diagnosis and interventional therapy of cesarean scar pregnancy, Journal of Interventional Radiology. 2020.10, (29): 1052-1055.
(7) Li N, Li H, Zhao D. Evaluation Endometrial Receptivity in Infertility Patients with Magnetic Resonance Perfusion-weighted Imaging, Journal of Clinical Radiology. 2013, 32(04): 535-538.
5. Published Books (since 2011)
(1) Li Hong, Yu Chengxin, Medical Imaging (Graduate Edition), Three Gorges Electronic Audio and Video Publishing House, 2015.05.
(2) Li Hong, Chen Juan, Analysis of Key and Difficult Cases of Medical Imaging, Hubei Science & Technology Press, 2018.10.
(3) Xia Ming, Shao Jianbo, Sun Tzu Yan, Li Hong, A Guide to MRI Film Reading, Peking University Medical Press, 2016.03.
(4) Zhao yun, Cui Xiangjun, Jian Daolin, Li Hong, Zhang Xianlin, Clinical Skills Training Course, Huazhong University of Science and Technology Press, 2011.07.
6. Research Projects (since 2011)
(1) Clinical Application of Reducing the Dose of TACE Chemotherapeutic Agents to Reduce Liver Fibrosis in Patients with Primary Liver Cancer.
(2) MRI Combined with MRS, IGF-II ADC Values and Tumor Markers for Early Diagnosis of Cervical Cancer Research.
(3) Molybdenum Target X-ray Combined with MRI Dynamic Enhancement, MRS and DWI in the Diagnosis of Early Breast Cancer.
(4) Effect of Stem Cell Transplantation Combined with PHGF and Salvia Miltiorrhiza Perfusion on Cirrhosis.
7. Honors and Awards (since 2011)
(1) 2016, 30 Years of Honorable Teaching.
(2) 2015, High-level Excellent Professional and Technical Personnel in the Health System of Yichang City.
(3) 2012, Excellent teacher of China Three Gorges University.
8. Membership of Professional Bodies
(1) Member, Intervention Committee of Chinese Anticancer Association.
(2) Member, Hubei Radiology Branch of Chinese Medical Association.
(3) Member, Hubei Interventional Medicine Branch of Chinese Medical Association.
(4) Chairman, Interventional Medicine Branch of Yichang Medical Association.
(5) Vice Chairman, Radiology Branch of Yichang Medical Association.
Dr. Zhang Bingyi
E-mail: zhangcarlsmith@126.com
Faculty: First People's Hospital in Yichang City (People's Hospital of China Three
Gorges University)
Job Title: Associate Chief Physician
1. Education
(1) September 2012-June 2015: Wuhan University
(2) September 2004-June 2007: Suzhou University
(3) September 1999-June 2004: China Three Gorges University
2. Professional Experiences
July 2007-now: First People's Hospital in Yichang City (People's Hospital of China Three Gorges University)
3. Research Directions
(1) Clinical Application of New Technique of Echocardiography
(2) Clinical Application of Transesophageal Echocardiography
4. Published Papers (since 2011)
(1) Chen Hongmin, Zhang Bingyi. Diagnosis of neonatal congenital left atrial appendage tumor by real-time three-dimensional echocardiography: a case report, Medical Imaging Technology in China. 2020, 36(09): 1440.
(2) Chen Hongmin, Zhang Bingyi. Research progress of speckle tracking technique in evaluating myocardial dysfunction in sepsis, Chinese Interventional Imaging and Therapeutics. 2020, 17(11): 689-692.
(3) Chen Xiaorong, Zhang Bingyi, Zhang Kun, Li Shuang. High frequency ultrasound diagnosis of synovial tuberculosis of hand, metacarpophalangeal joint with rice body formation: a case report. Journal of China Clinic Medical Imaging. 2019, 30(09): 683-684.
(4) Zhang Bingyi, Guo Ruiqiang, Ping Jie, Zhang Ling, Zhang Xiaofeng. Research progress of three-dimensional speckle tracking technique in evaluating left ventricular structure and function, Medical Recapitulate. 2018, 24(04): 787-793.
(5) Zhang Bingyi, Guo Ruiqiang, Zhou Qing, Ping Jie, Zhang Ling, Zhang Xiaofeng. Evaluation of immediate effect of single dialysis on left ventricular longitudinal systolic function in uremic patients by real-time three-plane automatic functional imaging, The Chinese Medical Report. 2018, 15(10): 122-126.
(6) Zhang Bingyi, Han Ling, Ping Jie, Zhang Ling, Yang Zishu. Ultrasonic diagnosis of giant angiosarcoma of breast: a case report, Journal of Ultrasound in Clinical Medicine. 2018, 20(05): 301+305.
(7) Zhang Bingyi, Ping Jie, Zhang Ling, Du Zhiyong, Gao Yang. Complete androgen insensitivity syndrome with seminoma: a case report, Journal of China Clinic Medical Imaging. 2018, 29(06): 456.
(8) Zhang Bingyi, Zha Yunhong, Li Junming, Ping Jie, Zhang Ling, Zhang Xiaofeng, Chen Xiaorong. Echocardiographic diagnosis of cardiac rhabdomyoma in children with tuberous sclerosis, Journal of China Clinic Medical Imaging. 2018, 29(09): 670-672.
(9) Han Ling, Zhang Wei, Zhang Bingyi, Zhan Leyun. Long non-coding RNA SOX2OT promotes cell proliferation and motility in human ovarian cancer, Experimental and Therapeutic Medicine. 2018, 15(2).
(10) Gong Yuanfeng, Zhang Bingyi, Liao Yadi, Tang Yunqiang, Mai Cong, Chen Tiejun, Tang Hui. Serum Insulin-Like Growth Factor Axis and the Risk of Pancreatic Cancer: Systematic Review and Meta-Analysis, Nutrients. 2017, 9(4).
(11) Zhan Leyun, Zhang Bingyi, Tan Yaojun, Yang Chengliang, Huang Chenhong, Wu Qiongya,Zhang Yulin, Chen Xiaobo, Zhou Mi, Shu Aihua. Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA), Medicine. 2017, 96(7).
(12) Gao Xiaoyan, Zhang Bingyi, Zhang Yulin, Ping Jie, Zhang Ling, Han Ling. Analysis of Diagnostic Value of High Frequency Color Doppler Ultrasound in Inflammatory Breast Cancer, Journal of china clinic medical imaging. 2016, 27(11): 781-783.
(13) Han Ling, Zhang Bingyi. Study on the relationship between psychosocial factors and the incidence of cervical intraepithelial neoplasia, Maternal and Child Health Care in China. 2015, 30(30): 5113-5116.
(14) Zhang Bingyi, Zhang Yulin, Han Ling, Gao Yang, Wang Xu, Ping Jie, Zhang Ling, Li Shuang. Comparative analysis of the value of high frequency color Doppler ultrasound and mammography in the early diagnosis of breast carcinoma in situ, Journal of china clinic medical imaging. 2015, 26(01): 14-17.
(15) Zhang Bingyi, Zhang Yulin, Zhang Ling. Diagnosis of right atrial giant myxoma by real-time three-dimensional echocardiography: a case report, Journal of China Clinic Medical Imaging. 2015, 26(09): 684.
(16) Zhang Bingyi, Ping Jie, Zhang Ling, Lin Yuan, Gao Yang, Xing Boyuan, Yang Zishu. Evaluation of acute effect of single dialysis on left ventricular function in uremic patients by tissue Doppler imaging, The Chinese Medical Report. 2015, 12(18): 153-157.
5. Research Projects (since 2011)
(1) 2019, Evaluation of Early Myocardial Dysfunction in Patients with Sepsis by 3D Speckle Tracing Technique, Hubei Province Joint Fund.
(2) 2015, Using 3D-STI to Evaluate the Effect of Single Dialysis on Left Ventricular Systolic Function in Patients with Uremia, Project of Yichang Science and Technology Bureau.
(3) 2015, Using 3D-STI to Evaluate the Effect of Different Hemodialysis Methods on the Global Systolic Function of Left Ventricle in Patients with Uremia and its Possible Mechanism, Project of Yichang Science and Technology Bureau.
(4) 2013, Minimally Invasive Atrial Septal Defect Closure by Transthoracic Transesophageal Ultrasound, Project of Yichang Science and Technology Bureau.
6. Honors and Awards (since 2011)
(1) 2020, Advanced Individual in the Hospital's Fight against the Covid-19 Outbreak.
(2) 2019, Advanced Individual in Early Screening and Comprehensive Intervention Program for Cardiovascular Risk Groups.
(3) 2019, Excellent Teacher of China Three Gorges University.
(4) 2018, the 13th Yichang City Natural Science Excellent Academic Paper Special Award.
(5) 2014, the 2nd Prize of the 11th Yichang Natural Science Excellent Academic Papers.
7. Membership of Professional Bodies
(1) Committee Member, Ultrasound Medicine Branch of Hubei Province Medical Association.
(2) Committee Member, Ultrasound Medicine Branch of Yichang City Medical Association.
(3) Committee Member, Ultrasound Imaging Group of Hubei Pediatric Medical Alliance, Imaging Medicine and Nuclear Medicine Sub-Union.
Prof. Dr. Liang Liang
E-mail: liangliang419519@163.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Professor, Chief Physician
1. Education
(1) September 2007-June 2010: Huazhong University of Science & Technology
(2) September 2003-June 2006: Hubei University of Traditional Chinese Medicine
2. Professional Experiences
(1) May 2011-now: First Clinical Medical College of China Three Gorges University
(2) July 2010-May 2011: The Central Hospital of Wuhan
(3) June 2006-September 2007: Yichang Hospital of Traditional Chinese Medicine
3. Research Directions
(1) Glaucoma, Anti Scarring
(2) Cataract
4. Published Papers (since 2011)
(1) Kang Zhang, Xiaohong Liu, Jun Shen, Zhihuan Li, Ye Sang, Liang Liang, et al. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography, Cell. DOI: 10.1016/j.cell.2020.04.045.
(2) Ping Wu, Liang Liang, ChunBao Chen, ShengQiong Nie. A child confirmed COVID-19 with only symptoms of conjunctivitis and eyelid dermatitis, Graefes Arch Clin Exp Ophthalmol. 2020 April 24, published online.
(3) Liang Liang, He Liye, Zhu Mengnan, Chen Baoji, Xiao Changyi. Protective effects of carnosic acid on retinal ganglion cells in acute ocular hypertension rats, International Ophthalmology, 2020 Apr 10.
(4) Ping Wu, Fang Duan, Chunhua Luo, Qiang Liu, Xingguang Qu, Liang Liang, Kaili Wu. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019(COVID-19) in Hubei, China, JAMA Ophthalmology, 2020.
(5) Liang Liang, Wu Ping. There may be virus in conjunctival secretion of patients with COVID-19, Acta Ophthalmol, 2020 Mar 18.
(6) Liang Liang, Zhu Mengnan, Chen Baoji, Wang Zeng, He Liye, Zhang Ran. Inhibitive effect of TAK-242 on Tenon's capsule fibroblasts proliferation in rat eyes, Int J Ophthalmol. 2019 Nov 18, 12(11): 1699-1707.
(7) Chen-Chen Zhao, Lian Zhu, Zheng Wu, Rui Yang, Na Xu, Liang Liang. Resveratrol-loaded peptide-hydrogels inhibit scar formation in wound healing through suppressing inflammation, Regenerative Biomaterials. 2019 Nov, published online.
(8) Liang Liang, Zhang Ran, He Liye. Corneal Hysteresis and Glaucoma, Int Ophthalmol, 2018 Sep 5.
(9) He Liye, Liang Liang, Zhu MN. Protective effect of carnoic acid on acute ocular hypertensive optic nerve injury, Chinese Journal of Experimental Ophthalmology. 2018, 36(04): 278-282.
(10) He Liye, Liang Liang, Zhu Mengnan. Application value of corneal lag in the diagnosis and treatment of glaucoma, Chinese Journal of Ophthalmology. 2017, 53(2): 140-143.
(11) Zhu Mengnan, He Liye, Liang Liang. Investigation of visual acuity and its influencing factors among medical college students in a university in Hubei Province, Hebei Medical College. 2017, 39(03): 460-462.
(12) Zhang Haijiang, Liang Liang. Effect of curcumin on retinal tissue structure and IL-23 and IL-17 expression in rats with retinal ischemia-reperfusion injury, International Journal of Ophthalmology. 2017, 17(08): 1423-1426.
(13) Zhu Mengnan, Liang Liang, he Liye. Application of nanotechnology in the diagnosis and treatment of glaucoma, New Advances in Ophthalmology. 2016, (10): 988-992.
(14) He Liye, Liang Liang, Liu Shuai. Application of RAPD in early diagnosis of glaucoma, New Advances in Ophthalmology. 2016, (06): 596-600.
(15) He Liye, Liang Liang. Research progress of Rho/ROCK channel inhibitors in glaucoma, Hainan Medicine. 2016, 27 (13): 2161-2164.
(16) Liang Liang, Li Qinghua, Jin Kun, et al. In Vitro and In Vivo Evaluation of a Novel Ocular Delivery System of 5-Fluorouracil Peptide Hydrogel, Asian Journal of Chemistry. 2014, 26(10).
(17) Xing-Hua Wang, Shuang Li, Liang Liang*, Xiao-Ding Xu, Xian-Zheng Zhang, Fa-Gang Jiang. Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye, Journal of Biomaterials Science, Polymer Edition. 2013, 24(10): 1185-97.
(18) Li W, Chen WJ, Liu W, Liang L, Zhang MC. Homemade lyophilized cross linking amniotic sustained-release drug membrane with anti-scarring role after filtering surgery in rabbit eyes, International Journal of ophthalmology. 2012, 5 (5): 555-561.
(19) Xiao-Ding Xu, Liang Liang, Han Cheng, Xin-Hua Wang, Fa-Gang Jiang, Ren-Xi Zhuo, Xian-Zheng Zhang. Construction of therapeutic glycopeptide hydrogel as a new substitute for antiproliferative drugs to inhibit postoperative scarring formation, Journal of Materials Chemistry. 2012, 22: 18164-18171.
(20) Liang Liang, Jun Yang, Qing-Hua Li, Ming Huo, Fa-Gang Jiang, Xiao-Ding Xu, Xian-Zheng Zhang. A Novel Targeting Drug Delivery System Based on Self-assembled Peptide Hydrogel, Journal of Biomaterials and Nanobiotechnology. 2011, 2: 622-625.
5. Published Books (since 2011)
(1) Wills Clinical Ophthalmology Color Atlas and Essential Notes: Glaucoma, Chief Editor and Translator, Tianjin Scientific Translation and Publishing Co., Lt.
(2) World Glaucoma Consensus Series: Glaucoma in Children, People's Medical Publishing House, China.
(3) World Glaucoma Consensus Series: Diagnosis of Open Angle Glaucoma, editor, People's Medical Publishing House.
6. Research Projects (since 2011)
(1) 2018.1-2021.12, Synthesize RGD Peptide Hydrogel to Inhibit Scarring after Glaucomatous Filtering Surgery.
(2) 2017.1-2019.12, Preparation of RGD Polypeptide Hydrogel and its Effect on Anti-scarring after Glaucoma Ostomy.
(3) 2015.1-2017.12, Effect of 5-Fu RGD Polypeptide Hydrogel Controlled-release System on Anti-scarring after Glaucoma Filtration.
(4) 2013.1-2015.12, Mechanism of Retinal Microglia in Optic Nerve Damage in Glaucoma.
7. Honors and Awards (since 2011)
(1) 2020, the 2rd Level of Medical Young Talents in Hubei Province.
(2) 2018.9, Excellent Teacher of China Three Gorges University.
(3) 2018.8, the 1st "Outstanding physician Award" in Yichang City.
(4) 2017.8, Famous Teacher of First Clinical College of China Three Gorges University.
(5) 2017.3, the Second-level Candidate of the Top-notch Medical Personnel Training Project in Yichang City.
(6) 2016.8, Excellent Teaching Teacher of First Clinical College of China Three Gorges University.
(7) 2016, Yichang Youth Science and Technology Award.
8. Membership of Professional Bodies
(1) Committee Member, Glaucoma Group, Ophthalmology Society, Chinese Medical Association.
(2) Committee Member, Glaucoma Professional Committee of Ophthalmology Branch of Chinese Medical Doctor Association.
(3) Committee Member, Cataract Group, Ophthalmology Committee of Chinese Society of Microcirculation.
(4) Committee Member, American Academy of Ophthalmology.
(5) Committee Member, Ophthalmologists Branch of Hubei Medical Doctor Association.
(6) Committee Member, Ophthalmology Branch of Hubei Medical Association.
(7) Committee Member, Ophthalmology Professional Committee of Hubei Association of Integrated Chinese and Western Medicine.
(8) Member of the Standing Committee, Ophthalmic Biomaterials Professional Committee of Hubei Society of Biomedical Engineering.
(9) Vice Chairman, Yichang Academy of Ophthalmology.
(10) Vice Chairman, Ophthalmologist Branch of Yichang Medical Doctor Association.
Dr. Gong Yuan
E-mail: gy-yc@163com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Chief Physician
1. Education
(1) September 2012-August 2015: Doctor's degree, Shanghai Jiao Tong University
(2) September 2006-June 2009: Master's degree, China Three Gorges University
(3) September 1994-June 1999: Bachelor's degree, Hubei Medical University
2. Professional Experiences
(1) August 2015-now: First Clinical Medical College of China Three Gorges University
(2) September 2005-September 2006: West China Hospital Affiliated to Sichuan University (Further education)
(3) June 1999-September 2005: First Clinical Medical College of China Three Gorges University
3. Research Directions
Pharmacology for Anesthesia
4. Published Papers (since 2011)
(1) Gong Y, Jiang JH, Li ST. Functional expression of human ɑ7 nicotinic acetylcholine receptor in human embryonic kidney 293 cells, Mol Med Rep. 2016.9, 14(3): 2257-2263.
(2) Gong Y, Wu J, Li ST. Immuno-enhancement effects of Lycium ruthenicum Murrpolysaccharide on cyclophosphamide-induced immunosuppression in mice, Int J clin Exp Med. 2015.11.15, 8(11): 20631-20637.
(3) Wu J, Zhang J, Gong Y, Li ST. Slowed relaxation of diaphragm in septic rats is associated with reduced expression of sarcoendoplasmic reticulum ca2+-ATPase genes SERCA1 and SERCA2, Muscle Nerve, 2016.4.22.
5. Research Projects (since 2011)
(1) Application of Accelerated Rehabilitation Anesthesia Management Strategy in Unilateral Total Hip Arthroplasty.
(2) Clinical Study of Imazolam Intranasal Administration for Preoperative Sedation in Children.
6. Membership of Professional Bodies
(1) National Member, Non-cardiac Surgery Anesthesia Branch of Chinese Society of Cardiothoracic and Vascular Anesthesiology.
(2) Vice Chairman, Anesthesiology Branch of Yichang Medical Association.
(3) Member, Anesthesiology Branch of Yichang Physician Association.
Dr. Qin Zhaojun
E-mail: 279522080@qq.com
Faculty: First People's Hospital in Yichang City (People's Hospital of China Three
Gorges University)
Job Title: Chief Physician
1. Education
(1) September 2011-December 2013: Ph.D. in Anesthesiology, Wuhan University
(2) September 2005-June 2008：M.M. in Anesthesiology, Xuzhou Medical University
(3) September 1998-June 2003: M.B. in Clinical Medicine, Yangtze University
2. Professional Experiences
(1) July 2008-now: Chief physician, First People's Hospital in Yichang City (People's Hospital of China Three Gorges University).
(2) August 2017-December 2017: Visiting Scholar, the Ohio State University College of Medicine, Columbus City, USA.
(3) August 2015-August 2016: Trainee physician, Zhongshan Hospital of Fudan University, Shanghai City, China.
(4) December 1995-August 2005: Attending doctor, the Second People’s Hospital of Songzi City Hubei Province, China.
3. Research Directions
(1) Clinical Anesthesia
(2) Pain Management
4. Published Papers (since 2011)
(1) Ma GS, Zhang Q, Qin ZJ. The research progress in the perioperative management of ambulatory surgery with the concept of enhanced recovery after surgery, Perioperative Safety and Quality Assurance. 2020, 4(6): 392-396.
(2) Li HB, Qin ZJ, Liao XP, et al. Perioperative anesthesia management for daytime hysteroscopy, Guangdong Medical Journal. 2019, 40(23): 3335-3338.
(3) Qin ZJ, Lai JP, Zhan LY, et al. Effects of dexmedetomidine combined with ropivacaine for ultrasound-guided transversus abdominis plane block on stress response in patients undergoing laparoscopic gynecological surgery, International Journal of Anesthesiology and Resuscitation. 2019, 40(9): 843-847.
(4) Zhang Q, Ma GS, Qin ZJ. Advance in clinical application of ultrasound-guided erector spinae plane block, Perioperative Safety and Quality Assurance. 2019, 3(5): 299-303.
(5) Qin ZJ, Xiang C, Li H, et al. The impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: a randomized controlled trial, BMC Anesthesiology. 2019, 19(1): 181.
(6) Qin ZJ, Zhou CS, Li SQ, et al. Perioperative management of total hip arthroplasty during daytime: a case report, Perioperative Safety and Quality Assurance. 2019, 3(04): 226-228.
(7) Li HB, Qin ZJ, Zhan LY, et al. Comparison of different doses of dexmedetomidine supplement with ropivacaine for ultrasound-guided transversus abdominis plane block on postoperative analgesia in patients undergoing laparoscopic gynecological surgery, Perioperative Safety and Quality Assurance. 2019, 3(2): 80-84.
(8) Liu TT, Qin ZJ. Current status and progress of research on analgesia after laparoscopic surgery, International Journal of Anesthesiology and Resuscitation. 2018, 39(5): 505-508.
(9) Qin ZJ, Xiang CY, Zhan LY, et al. Developing a Quality Assurance System for Cultivating Scientific Research Capability of Graduate Students Majoring in Clinical Medicine under the New Deal, China Higher Medical Education. 2018, 5: 129-130.
(10) Qin ZJ, Zhan LY, Xiang CY, et al. Efficacy of oxycodone for intravenous analgesia after off-pump coronary artery bypass grafting, International Journal of Anesthesiology and Resuscitation. 2018, 39(1): 35-38, 52.
(11) Qin ZJ, Zhan LY, Xiang CY, et al. Clinical application of dexmedetomidine as an adjunct to ropivacaine in ultrasound-guided ilioinguinal/iliohypogastric nerve block for geratic inguinal hernia repair, Chinese Journal of Hernia and Abdominal Wall Surgery. 2017, 11(6): 460-464.
(12) Qin ZJ, Zhan LY, Xiang CY, et al. Analysis of analgesic effect of sufentanil combined with wound continuous infusion of ropivacaine after cardiac surgery, Chongqing Medical Journal. 2017, 46(8): 1110-1112.
(13) Zhan LY, Qin ZJ, Zhou W, et al. Application of guiding tube core for tracheal intubation during management of difficult airway, Guangdong Medical Journal. 2016, 37(15): 2284-2286.
5. Published Books (since 2011)
Wei SM, Qin ZJ, Wang CH, et al. Modern Anesthesiology and Comfortable Medical. Changchun: Jilin Science and Technology Press, 2017.
6. Research Projects (since 2011)
(1) 2020, A Comparative Study of Arthroscopic Day Surgery and Traditional Surgical Mode Based on the Concept of Enhanced Recovery after Surgery, Host, Research Project of Yichang City Science and Technology Bureau.
(2) 2019, A Quantitative and Qualitative Study on the Parturient Delivery Experience during Caesarean Section under the Companion Delivery Mode, Host, Research Project of Hubei Province Health Commission.
(3) 2017, The Mechanism Study of SHN-2/MHC-1 Regulating Synaptic Plasticity in the Lateral Habenular Region Inducing Postpartum Depression, Participant, Youth Foundation of National Natural Science Foundation of China.
(4) 2016, The Role of Parkin/DJ-1-regulated Mitochondrial Autophagy in Alleviating Cerebral Ischemia-reperfusion Injury in Mice after Distal Limb Ischemia Pretreatment and its Mechanism, Participant, Youth Foundation of Natural Science Foundation of Hubei Province.
(5) 2016, Construction of Quality Assurance System of Research Ability Cultivation for Postgraduates of Clinical Medicine Specialty under New Deal, Host, Research Project of Higher Education Research Institute of China Three Gorges University.
(6) 2015, Brg1 Restores Diabetic Heart Sensitivity to Ischemic Post-processing through Activation of STAT3, Participant, High-tech Industry Development Special Project of Hubei Province.
(7) 2012, Effect of Ulinastatin on Lung Injury Induced by Transfusion of Autologous Blood in Patients Undergoing Orthopedic Surgery, Host, Research Project of Yichang City Science and Technology Bureau.
(8) 2010, The Study of Effect of Emulsified Isoflurane Pretreatment on Renal Ischemia/Reperfusion Injury in Rats and its Mechanism, Principal Participant, Research Project of Hubei Province Health Commission.
7. Honors and Awards (since 2011)
(1) 2017, the Top Medical talent of Yichang City.
(2) 2016, the 2nd Yichang’s Science-Technology Progress Prize.
(3) 2015, the 2nd Yichang’s Science-Technology Progress Prize.
(4) 2015, the Senior Outstanding Professional and Technical Personnel of Yichang City.
8. Membership of Professional Bodies
(1) Member, Chinese Research Hospital Association Anesthesiology Branch Youth Commission.
(2) Member, Chinese Association of Plastic Aesthetics Anesthesia and Sedation and Analgesia Branch.
(3) Member, Chinese Society of Cardiothoracic and Vascular Anesthesiology Non-cardiac Surgery Anesthesiology Branch.
(4) Member, Yichang Medical Association Anesthesiology Branch.
Dr. Cui Lei
E-mail: leileicui@126.com
Faculty: First Clinical Medical College of China Three Gorges University
Job Title: Associate Chief Physician
1. Education
(1) September 2010-June 2013: Wuhan University
(2) September 2004-June 2007: China Three Gorges University
(3) September 1999-June 2004: First Medical University of Shandong
2. Professional Experiences
(1) July 2013-now: First Clinical Medical College of China Three Gorges University
(2) September 2007-June 2010: Second Clinical Medical College of China Three Gorges University
3. Research Directions
(1) The Mechanism of Keloids
(2) Development of Traditional Chinese Medicine for Hypertrophic Scar
4. Published Papers (since 2011)
(1) Lei Cui, Jian Song, Liting Wu, Liming Huang, Yanlin Wang, Yingdi Huang, Han Yu, Yiling Huang, C.C. You, Jiayou Ye. Smac is another pathway in the anti-tumour activity of Trichosanthin and reverses Trichosanthin resistance in CaSki cervical cancer cells, Biomedicine & Pharmacotherapy. 2015, 69: 119-124.
(2) Lei Cui, Liming Huang, Yanlin Wang, Yiling Huang, Yurong Huang. Comparison of MRI and endoscope ultrasound detection in preoperative T/N staging of gastric cancer, Mol Clin Oncol. 2013, 1(4): 699-702.
(3) Lei Cui, Yanlin Wang, Yurong Huang, Han Yu, Yiling Huang, Liting Wu, Liming Huang. Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells, PLos One. 2012, 7(12): e52310-e52310.
(4) Lei Cui, Jian Song, Liting Wu, Luhui Cheng, Aijun Chen, Yanlin Wang, Yingdi Huang, Liming Huang. Role of Annexin A2 in the EGF-inducedepithelial-mesenchymal transition in human CaSki cells, ONCOLOGY LETTERS. 2016.11, DOI: 10.3892/ol.2016.5406.
5. Research Projects (since 2011)
(1) 2017-2019, Trichosanthin Regulates Epithelial Mesenchymal Transition Associated miRNAs and Inhibits Immune Escape in Breast Cancer, National Natural Science Project.
(2) 2015-2016, Exsomes’ miR155 Regulates Epithelial Mesenchymal Transition and Induces Treg Proliferation Experimental Research, Provincial Natural Science Project.
